GLP-1 medications, such as Semaglutide and Tirzepatide, are commonly prescribed for managing conditions like type 2 diabetes and obesity. These medications require gradual dose escalation to minimize side effects and optimize effectiveness. Below, we provide an overview of general dosing principles and example schedules for these medications.

For certain cases, such as a fixed dose of 1.5 mg weekly for Tirzepatide, your provider may prescribe a specific regimen. For example, one schedule involves injecting 30 units subcutaneously once per week for four weeks, ensuring the same day is chosen each week. However, this may not apply universally and should be confirmed with your provider.

Your healthcare provider will tailor your dosing schedule based on your individual response and tolerance to the medication. Always consult your provider before making any changes to your dosing regimen. Consistency and adherence to the prescribed schedule are key to achieving the best outcomes.